ArticleClinical rheumatology2026
Double-negative B cells mediate the causal association between rheumatoid arthritis and interstitial lung disease: a two-step Mendelian randomization mediation study.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundRheumatoid arthritis (RA) elevates interstitial lung disease (ILD) risk, yet the underlying mediating immune cells remain unknown. This study sought peripheral immune phenotypes driving the causal pathway from RA to ILD.
methodsA two-step Mendelian randomization (MR) mediation analysis was performed using European GWAS data: RA (14,361 cases/43,923), 731 immune cell traits, and ILD from FinnGen R13 (6,733 cases/493,453). Step 1 applied inverse variance weighted (IVW) MR to estimate RA effects on immune cells; Step 2 tested immune cell effects on ILD. Mediation was validated via joint significance and parametric bootstrapping (10,000 resamples) with BCa 95% confidence intervals (CIs).
resultsRA exerted a causal risk-increasing effect on ILD (β = 0.166, P = 4.26 × 10⁻⁸). Fifty-three immune traits showed nominal significance in Step 1, 15 passing FDR correction. CD19⁺IgD⁻CD27⁻ DN B cells reached nominal significance (P = 0.028) but not FDR significance (q = 0.512) in Step 1, yet were the only trait significantly associated with ILD in Step 2 (β₂ = 0.060, P = 0.027). Bootstrapping verified a small but significant indirect effect (β = 0.0039, 95% BCa CI 0.0009-0.0153, P = 0.050; mediation proportion = 2.3%), consistent across sensitivity tests.
conclusionsDN B cells partially mediate the causal RA-ILD relationship. Our genetic evidence highlights B cell dysfunction as a mechanistic link and identifies DN B cells as candidate biomarkers for RA-related interstitial lung complications. Key Points • Rheumatoid arthritis (RA) is associated with elevated interstitial lung disease (ILD) risk, yet the underlying causal pathway remains poorly defined. • A two-step Mendelian randomization mediation design was applied to identify double-negative (DN) B cells (CD19⁺IgD⁻CD27⁻) as a potential mediator linking RA to ILD. • Genetically predisposed RA was causally associated with increased DN B cell proportions, which in turn were associated with higher ILD risk. • These findings indicate DN B cells may serve as a potential immunological link between RA and ILD, meriting further investigation as a candidate direction for early intervention research.
Indexed as
Identifiers
42862269What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.